Canadian Antimicrobial Resistance Surveillance System - Update 2020

Executive summary

This 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report provides a detailed assessment of antimicrobial resistance (AMR) in Canada. This report also provides recent information on the amount of antimicrobials used in humans and animals, as antimicrobial use (AMU) is one of the key drivers of AMR.

The methodology used for this report prioritizes AMR and AMU data acquired by the Public Health Agency of Canada (PHAC) and its partners. These data are often characterized by a high degree of national representation, but are not fully comprehensive. While this publication does not include projections as a result of mathematical modeling or the calculation of cost estimates, the timely availability of these data complement the existing body of evidence.

  • Globally, infections caused by antimicrobial resistant organisms are becoming more frequent, leading to increased illness, death and rising healthcare costsFootnote 1 .
  • Indicators show that the situation is worsening in Canada.


Download the entire report
(PDF format, 1.32 MB, 108 pages)

Contact us:

Organization: Public Health Agency of Canada

Published: 2020-06-29

Between 2014 and 2018

This publication contributes to the body of evidence needed to inform the development of effective antimicrobial stewardship and infection prevention and control strategies, which work towards limiting the rise of AMR infections.

Priority antimicrobial-resistant organisms in Canada

Page details

Date modified: